Your fact-checks will appear here
The weight of rigorously conducted 2023 and systematic reviews concluded that ivermectin does not reduce mortality, hospitalization, or meaningful clinical progression for COVID-19 in typical (non-) s...
There are no universally agreed clinical guidelines that endorse off‑label high‑dose ivermectin for viral illnesses; major U.S. guidance notes that antiviral concentrations seen in vitro would require...
have been authorized after meeting regulatory standards and are subject to unprecedented safety monitoring; evidence from multiple reviews and surveillance systems shows they substantially reduce seve...
Available sources provided by the user contain no mention of a medicinal product or compound named “gelatide.” The public records and guidance pages from EMA, MHRA and TGA in the supplied results disc...
Ivermectin is primarily an antiparasitic medicine used to treat human and animal parasitic infections such as onchocerciasis (river blindness), strongyloidiasis, scabies and other worm infestations; i...